Inhibitory activity of liposomal flavonoids during oxidative metabolism of human neutrophils upon stimulation with immune complexes and phorbol ester

Drug Delivery

Volumn 19, Issue 4, 2012, Pages 177-187

  Landi Librandi, Ana Paula ^a   Caleiro Seixas Azzolini, Ana Elisa ^a   De Oliveira, Carlos Alberto ^b   Lucisano Valim, Yara Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Drug delivery; Flavonoid; Liposome; Neutrophil; Oxidative metabolism

Indexed keywords

ALCOHOL; CYTOCHALASIN B; FLAVONOID; GALANGIN; HYDROXYL GROUP; KAEMPFEROL; LIPOSOME; LUCIGENIN; LUMINOL; MYRICETIN; PHORBOL ESTER; QUERCETIN; SUPEROXIDE;

AEROBIC METABOLISM; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL METABOLISM; CELL STIMULATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; HUMANS; LIPOSOMES; MALE; NEUTROPHILS; OXIDATIVE STRESS; PHORBOL ESTERS; REACTIVE OXYGEN SPECIES;

EID: 84861818173     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.679710     Document Type: Article

References (60)

1. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-3521.
2. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-3017.
3. Dinauer MC. Disorders of neutrophil function: an overview. Methods Mol Biol 2007;412:489-504.
4. Baldridge CW, Gerard RW. The extra respiration of phagocytes. Am J Physiol 1933;103:235.
5. Sbarra AJ, Karnovsky ML. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 1959;234:1355-1362.
6. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fbrosis. Torax 2010;65:57-62.
7. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
8. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991;77:673-686.
9. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-44.
10. Jensen PØ, Lykkesfeldt J, Bjarnsholt T, Hougen HP, Høiby N, Ciofu O. Poor Antioxidant Status Exacerbates Oxidative Stress and Infammatory Response to Pseudomonas aeruginosa Lung Infection in Guinea Pigs. Basic Clin Pharmacol Toxicol 2012;110:353-358.
11. Middleton E Jr, Kandaswami C, Teoharides TC. The effects of plant favonoids on mammalian cells: implications for infammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
12. Kanashiro A, Kabeya LM, Grael C F, Jordão CO, Azzolini AE, Lopes JL, Lucisano-Valim YM. Sesquiterpene lactones from Lychnophora pohlii: neutrophil chemiluminescence inhibition and free radical scavenger activity. J Pharm Pharmacol 2006;58:853-858.
13. Kabeya LM, da Silva CH, Kanashiro A, Campos JM, Azzolini AE, Polizello AC, Pupo MT, Lucisano-Valim YM. Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures. Eur J Med Chem 2008;43:996-1007.
14. Moreira MR, Kanashiro A, Kabeya LM, Polizello AC, Azzolini AE, Curti C, Oliveira CA, et al. Neutrophil effector functions triggered by Fc-γ and/or complement receptors are dependent on B-ring hydroxylation pattern and physicochemical properties of favonols. Life Sci 2007;81:317-326.
15. Kanashiro A, Kabeya LM, Polizello AC, Lopes NP, Lopes JL, Lucisano-Valim YM. Inhibitory activity of favonoids from Lychnophora sp. on generation of reactive oxygen species by neutrophils upon stimulation by immune complexes. Phytother Res 2004;18:61-65.
16. Limasset B, Ojasoo T, le Doucen C, Doré JC. Inhibition of chemiluminescence in human PMNs by monocyclic phenolic acids and favonoids. Planta Med 1999;65:23-29.
17. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release 2006;113:189-207.
18. Suntres ZE, Omri A, Shek PN. Pseudomonas aeruginosa-induced lung injury: role of oxidative stress. Microb Pathog 2002;32:27-34.
19. Mandal AK, Das N. Sugar coated liposomal favonoid: a unique formulation in combating carbontetrachloride induced hepatic oxidative damage. J Drug Target 2005;13:305-315.
20. Mandal AK, Das S, Mitra M, Chakrabarti RN, Chatterjee M, Das N. Vesicular favonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. J Exp Ter Oncol 2008;7:123-133.
21. Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, Oteiza PI. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic Biol Med 2003;34:84-92.
22. Oteiza PI, Erlejman AG, Verstraeten S V, Keen CL, Fraga CG. Flavonoid-membrane interactions: a protective role of favonoids at the membrane surface? Clin Dev Immunol 2005;12:19-25.
23. Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973;298:1015-1019.
24. Lucisano YM, Mantovani B. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG. J Immunol 1984;132:2015-2020.
25. Kabat EA, Mayer MM. Experimental Immunochemistry. 2nd Edition. Charles C. Tomas: Springfeld, Illinois, 1961.
26. Fahey JL, Wunderlich J, Mishell R. The immunoglobulins of mice. I. Four major classes of immunoglobulins: 7s γ-2-, 7s γ-1-, γ-1a (β-2a)-, and 18s γ-1m-globulins. J Exp Med 1964;120:223-242.
27. Lucisano-Valim YM, Kabeya LM, Kanashiro A, Russo-Carbolante EM, Polizello AC, Azzolini AE, Silva SC, et al. A simple method to study the activity of natural compounds on the chemiluminescence of neutrophils upon stimulation by immune complexes. J Pharmacol Toxicol Methods 2002;47:53-58.
28. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988;37:837-841.
29. Oliveira CA, Azzolini AECS, Silva SC, Kanashiro A, Kabeya LM, Azevedo APGB, et al. Avaliação bioquímica e ultraestrutural da interação de imunocomplexos de IgG com leucócitos polimorfonucleares: efeito de antioxidantes naturais. Eclética Química 2002;27A:273-283.
30. Johnson KJ, Varani J, Smolen JE. Neutrophil activation and function in health and disease. Immunol Ser 1992;57:1-46
31. dos Santos EOL. Mecanismo de ação de favonóides no metabolismo oxidativo e na fagocitose de neutróflos humanos desencadeados por receptores Fc gama e CR. Dissertação de Mestrado. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, USP, 82p, 2010.
32. Erlejman AG, Verstraeten S V, Fraga CG, Oteiza PI. The interaction of favonoids with membranes: potential determinant of favonoid antioxidant effects. Free Radic Res 2004;38:1311-1320.
33. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747.
34. Howard TH, Casella J, Lin S. Correlation of the biologic effects and binding of cytochalasins to human polymorphonuclear leukocytes. Blood 1981;57:399-405.
35. Williams AJ, Cole PJ. Polymorphonuclear leucocyte membrane-stimulated oxidative metabolic activity\the effect of divalent cations and cytochalasins. Immunology 1981;44:847-858.
36. Malawista SE, Gee JB, Bensch KG. Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages. Yale J Biol Med 1971;44:286-300.
37. Zigmond SH, Hirsch JG. Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res 1972;73:383-393.
38. Roos D, Homan-Müller JW, Weening RS. Effect of cytochalasin B on the oxidative metabolism of human peripheral blood granulocytes. Biochem Biophys Res Commun 1976;68:43-50.
39. Goldstein IM, Roos D, Kaplan HB, Weissmann G. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest 1975;56:1155-1163.
40. Root RK, Metcalf JA. H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest 1977;60:1266-1279.
41. Williams AJ, Cole PJ. In vitro stimulation of alveolar macrophage metabolic activity by polystyrene in the absence of phagocytosis. Br J Exp Pathol 1981;62:1-7.
42. Vuotto ML, Miranda R, Ritieni A, Basile A, Ricciardi L, Di Prisco R, Nicolosi G, Mascolo N. Improvement of (+)-catechin inhibitory activity on human PMN respiratory burst by (+)-3-O-propionyl and (-)-3-O-valeryl substitution. J Pharm Pharmacol 2003;55:399-405.
43. Chen YC, Shen SC, Lee WR, Hou WC, Yang LL, Lee TJ. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 2001;82:537-548.
44. Regnault C, Roch-Arveiller M, Tissot M, Sarfati G, Giroud JP, Postaire E, Hazebroucq G. Effect of encapsulation on the anti-infammatory properties of superoxide dismutase after oral administration. Clin Chim Acta 1995;240:117-127.
45. Mukherjee S, Stone WL, Yang H, Smith MG, Das SK. Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J Biochem Mol Toxicol 2009;23:143-153.
46. Fan J, Shek PN, Suntres ZE, Li YH, Oreopoulos GD, Rotstein OD. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 2000;128:332-338.
47. Simões SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, Cruz ME, et al. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes. J Control Release 2005;103:419-434.
48. Corvo ML, Boerman OC, Oyen WJ, Jorge JC, Cruz ME, Crommelin DJ, Storm G. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an infammation model. Pharm Res 2000;17:600-606.
49. Luisa Corvo M, Jorge JC, van't Hof R, Cruz ME, Crommelin DJ, Storm G. Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. Biochim Biophys Acta 2002;1564:227-236.
50. Williams AS, Jones SG, Goodfellow RM, Amos N, Williams BD. Interleukin-1β (IL-1β) inhibition: a possible mechanism for the anti-infammatory potency of liposomally conjugated methotrexate formulations in arthritis. Br J Pharmacol 1999;128:234-240.
51. Harigai T, Hagiwara H, Ogawa Y, Ishizuka T, Kaneda S, Kimura J. Prednisolone phosphate-containing TRX-20 liposomes inhibit cytokine and chemokine production in human fbroblast-like synovial cells: a novel approach to rheumatoid arthritis therapy. J Pharm Pharmacol 2007;59:137-143.
52. Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 2003;48:2059-2066.
53. Van Dyke K, Castranova V. Cellular Chemiluminescence. Boca Raton: CRC Press, 1987.
54. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efciencies. Meth Enzymol 1990;186:343-355.
55. Dorta DJ, Pigoso AA, Mingatto FE, Rodrigues T, Pestana CR, Uyemura SA, Santos AC, Curti C. Antioxidant activity of favonoids in isolated mitochondria. Phytother Res 2008;22:1213-1218.
56. Nessa F, Ismail Z, Mohamed N. Xanthine oxidase inhibitory activities of extracts and favonoids of the leaves of Blumea balsamifera. Pharm Biol 2010;48:1405-1412.
57. Selloum L, Reichl S, Müller M, Sebihi L, Arnhold J. Effects of favonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils. Arch Biochem Biophys 2001;395:49-56.
58. Landi-Librandi A P, de Oliveira CA, Azzolini AE, Kabeya LM, Del Ciampo JO, Bentley M V, Lucisano-Valim YM. In vitro evaluation of the antioxidant activity of liposomal favonols by the HRP-H2O2-luminol system. J Microencapsul 2011;28:258-267.
59. Stevens MD, Miller EJ, Cohen AB. Search for drugs that may reduce the load of neutrophil azurophilic granule enzymes in the lungs of patients with emphysema. Exp Lung Res 1989;15:663-680.
60. Landi-Librandi AP, Chrysostomo TN, Azzolini AECS, Marzocchi-Machado CM, de Oliveira CA, Lucisano-Valim YM. Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of their stability and clearance. J Liposome Res (In Press).